We offer Sponsors and CROs a better way of identifying, visualizing, managing, and documenting trial risks that could compromise patient safety and delay the approval of Investigational Products. Underpinned by Central Statistical Monitoring, a technique thatโs currently being investigated by the Food and Drug Administration (FDA) for selecting sites for inspection, our cloud-based products are deployed to support traditional onsite monitoring, medical review and quality to drive a Risk-Based Approach to Study Execution.
โ ๏ธ
Votre navigateur est mal|non supportรฉ !
Nous vous conseillons d'utiliser un navigateur moderne comme
Edge,
Chrome ou
Firefox